Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

BACKGROUND: Primary progressive aphasia (PPA) is a clinical dementia syndrome. Impairments in language (speaking, reading, writing, and understanding) are the primary and persistent symptoms. These impairments progress insidiously and devastate communication confidence, participation, and quality of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Angela C., Rademaker, Alfred W., Salley, Elizabeth Ann, Mooney, Aimee, Morhardt, Darby, Fried-Oken, Melanie, Weintraub, Sandra, Mesulam, Marsel, Rogalski, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190461/
https://www.ncbi.nlm.nih.gov/pubmed/35698099
http://dx.doi.org/10.1186/s13063-022-06162-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190461/
https://www.ncbi.nlm.nih.gov/pubmed/35698099
http://dx.doi.org/10.1186/s13063-022-06162-7

Ejemplares similares